文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Biological Characteristics of Umbilical Cord Mesenchymal Stem Cells and Its Therapeutic Potential for Hematological Disorders.

作者信息

Shang Yufeng, Guan Haotong, Zhou Fuling

机构信息

Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China.

出版信息

Front Cell Dev Biol. 2021 May 3;9:570179. doi: 10.3389/fcell.2021.570179. eCollection 2021.


DOI:10.3389/fcell.2021.570179
PMID:34012958
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8126649/
Abstract

Umbilical cord mesenchymal stem cells (UC-MSCs) are a class of multifunctional stem cells isolated and cultured from umbilical cord. They possessed the characteristics of highly self-renewal, multi-directional differentiation potential and low immunogenicity. Its application in the field of tissue engineering and gene therapy has achieved a series of results. Recent studies have confirmed their characteristics of inhibiting tumor cell proliferation and migration to nest of cancer. The ability of UC-MSCs to support hematopoietic microenvironment and suppress immune system suggests that they can improve engraftment after hematopoietic stem cell transplantation, which shows great potential in treatment of hematologic diseases. This review will focus on the latest advances in biological characteristics and mechanism of UC-MSCs in treatment of hematological diseases.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b29/8126649/33d80cce1e96/fcell-09-570179-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b29/8126649/1625905facb1/fcell-09-570179-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b29/8126649/33d80cce1e96/fcell-09-570179-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b29/8126649/1625905facb1/fcell-09-570179-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b29/8126649/33d80cce1e96/fcell-09-570179-g002.jpg

相似文献

[1]
Biological Characteristics of Umbilical Cord Mesenchymal Stem Cells and Its Therapeutic Potential for Hematological Disorders.

Front Cell Dev Biol. 2021-5-3

[2]
Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation.

Biol Blood Marrow Transplant. 2007-12

[3]
A collagen scaffold loaded with human umbilical cord-derived mesenchymal stem cells facilitates endometrial regeneration and restores fertility.

Acta Biomater. 2019-5-7

[4]
The immunologic and hematopoietic profiles of mesenchymal stem cells derived from different sections of human umbilical cord.

Acta Biochim Biophys Sin (Shanghai). 2014-12

[5]
Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).

Circ Res. 2017-10-27

[6]
Isolation and proliferation of umbilical cord tissue derived mesenchymal stem cells for clinical applications.

Cell Tissue Bank. 2016-6

[7]
Impact of adipose tissue or umbilical cord derived mesenchymal stem cells on the immunogenicity of human cord blood derived endothelial progenitor cells.

PLoS One. 2017-5-31

[8]
Immunomodulatory function of whole human umbilical cord derived mesenchymal stem cells.

Mol Immunol. 2017-7

[9]
[Comparative characterization of mesenchymal stem cells from human umbilical cord tissue and bone marrow].

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008-2

[10]
Bioactive molecules derived from umbilical cord mesenchymal stem cells.

Acta Histochem. 2016-10

引用本文的文献

[1]
Stem cell and gene therapies for leukodystrophies.

Mol Ther Methods Clin Dev. 2025-7-31

[2]
Intranasal administration of stem cell derivatives for the treatment of AD animal models: a systematic review and meta-analysis.

Stem Cell Res Ther. 2025-7-28

[3]
Mitigation of Ferroptosis in Diabetic Kidney Disease Through Mesenchymal Stem Cell Intervention via the Smad2/3/METTL3/S1PR1 Axis.

FASEB J. 2025-6-30

[4]
Isolation and characterization of human cKIT positive amniotic fluid stem cells obtained from pregnancies with spina bifida.

Sci Rep. 2025-6-6

[5]
Advancements in Stem Cell Applications for Livestock Research: A Review.

Vet Sci. 2025-4-23

[6]
Efficacy and Potential Mechanisms of Umbilical Cord-Derived Mesenchymal Stem Cells in the Treatment of Ischemic Stroke in Animal Models: A Meta-Analysis.

CNS Neurosci Ther. 2025-4

[7]
Mesenchymal stem cells and their extracellular vesicle therapy for neurological disorders: traumatic brain injury and beyond.

Front Neurol. 2025-2-5

[8]
Efficacy of Fetal Wharton's Jelly Mesenchymal Stem Cells-Derived Small Extracellular Vesicles in Metabolic Syndrome.

Biomolecules. 2025-1-1

[9]
TET3-facilitated differentiation of human umbilical cord mesenchymal stem cells into oligodendrocyte precursor cells for spinal cord injury recovery.

J Transl Med. 2024-12-20

[10]
Human umbilical cord mesenchymal stem cells improve bone marrow hematopoiesis through regulation of bone marrow adipose tissue.

Mol Cell Biochem. 2025-5

本文引用的文献

[1]
Allogeneic human umbilical cord Wharton's jelly stem cells increase several-fold the expansion of human cord blood CD34+ cells both in vitro and in vivo.

Stem Cell Res Ther. 2020-12-9

[2]
What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment?

Stem Cell Res Ther. 2020-12-1

[3]
Comprehensive proteomic analysis of exosomes derived from human bone marrow, adipose tissue, and umbilical cord mesenchymal stem cells.

Stem Cell Res Ther. 2020-11-27

[4]
Co-transplantation of mesenchymal stem cells makes haploidentical HSCT a potential comparable therapy with matched sibling donor HSCT for patients with severe aplastic anemia.

Ther Adv Hematol. 2020-10-29

[5]
Mesenchymal stromal cells reprogram monocytes and macrophages with processing bodies.

Stem Cells. 2021-1

[6]
Human mesenchymal stem cells derived from umbilical cord and bone marrow exert immunomodulatory effects in different mechanisms.

World J Stem Cells. 2020-9-26

[7]
Efficacy, safety and immunological profile of combining rituximab with belimumab for adults with persistent or chronic immune thrombocytopenia: results from a prospective phase 2b trial.

Haematologica. 2021-9-1

[8]
Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.

Cytotherapy. 2020-12

[9]
Pathogenesis of immune thrombocytopenia in common variable immunodeficiency.

Autoimmun Rev. 2020-7-17

[10]
Regeneration of the rotator cuff tendon-to-bone interface using umbilical cord-derived mesenchymal stem cells and gradient extracellular matrix scaffolds from adipose tissue in a rat model.

Acta Biomater. 2020-9-15

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索